Global Parasitology Identification Market, By Products (Consumables and Accessories, Devices), Methods (Microscopic Identification, Fecal Identification, Immunological Techniques, Morphological Identification, Molecular Techniques, Rapid Diagnostic Tests (RDTs), Maldi-TOF MS, Others), Pathogen Type (Protozoan, Helminths, Arthropodes, Tapeworm, Ectoparast), Sample (Feces, Blood, Urine, Cerebrospinal Fluid (CSF), Serum and Plasma, Others), Stool Concentration and Preparation (Concentration Technique, Un-Concentration Technique), End User (Diagnostic Centers, Hospitals, Clinics, Ambulatory Surgical Centres, Others) – Industry Trends and Forecast to 2030.
Parasitology Identification Market Analysis and Size
The study of parasites, their hosts, and their interactions is known as parasitology. Regarding biology, parasitology focuses more on how parasites live than on the organisms or environments being studied. It thus incorporates ideas from various disciplines and applies methods from disciplines like cell biology, bioinformatics, biochemistry, molecular biology, immunology, genetics, evolution, and ecology.
Data Bridge Market Research analyses that the parasitology identification market, valued at USD 4,092.15 million in 2022, will reach USD 6,522.27 million by 2030, growing at a CAGR of 6% during the forecast period of 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Parasitology Identification Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Products (Consumables and Accessories, Devices), Methods (Microscopic Identification, Fecal Identification, Immunological Techniques, Morphological Identification, Molecular Techniques, Rapid Diagnostic Tests (RDTs), Maldi-TOF MS, Others), Pathogen Type (Protozoan, Helminths, Arthropodes, Tapeworm, Ectoparast), Sample (Feces, Blood, Urine, Cerebrospinal Fluid (CSF), Serum and Plasma, Others), Stool Concentration and Preparation (Concentration Technique, Un-Concentration Technique), End User (Diagnostic Centers, Hospitals, Clinics, Ambulatory Surgical Centres, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Abbott (U.S.), BD (U.S.), bioMérieux, Inc (France), Bruker (U.S.), Quest Diagnostics (U.S.), Akron Biotech (U.S.), Thermo Fisher Scientific Inc (U.S.), altona Diagnostics GmbH (Germany), Biomerica (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Creative Diagnostics (U.S.), Luminex Corporation (U.S.), Meridian Bioscience, Inc. (U.S.), R-Biopharm AG (Germany), Shimadzu Corporation (Japan), Institut Virion/Serion (Germany), VWR International, LLC. (U.S.), Hardy Diagnostics (U.S.), TECHLAB, Inc. (U.S.), Alpha-Tec (U.S.), Medical Chemical Corporation (MCC). (U.S.)
|
|
Market Opportunities
|
|
Market Definition
The study of parasites, their hosts, and their interactions is known as parasitology. In the symbiotic relationship known as parasitism, one organism, the parasite, gains an advantage at the expense of another, the host typically an organism of a different species. The association could be harmful to the host as well. The focus of parasitology as a biological field is not on the organism or environment under consideration but on how they live. As a result, it synthesizes knowledge from various disciplines and incorporates methods from various scientific disciplines, including cell biology, bioinformatics, biochemistry, molecular biology, immunology, genetics, evolution, and ecology.
Parasitology Identification Market Dynamics
Drivers
- Rapid diagnostic tool expansion fuels demand
The demand for the parasitology identification market has increased in developed and developing countries due to the rise in strategic initiatives by players worldwide to improve healthcare systems. Rapid diagnostic tools for detecting and treating infectious and parasitic diseases, rising disposable income, and parasitology identification all contribute to the growth of the parasitology identification market. The market will grow during the anticipated period due to the strategic initiative to promote parasitology identification and explore emerging markets.
- Modern techniques enable market expansion
Parasite diagnosis requires parasite isolation with culture, expansion, and subsequent sequence testing. Significant concerns exist about the requirement for state-of-the-art tools for identifying parasitic strains due to the widespread infections caused by various pathogen types, such as protozoans, helminths, and ectoparasites. Numerous conventional techniques have been employed for years to identify parasitic strains. In diagnostic labs, advanced, contemporary methods that are more accurate and sensitive have also been used. Modern techniques such as MALDI-TOF MS, Rapid Diagnostic tests, and others are considered for a quick and precise diagnosis of the parasitic strain, which further fuels the market.
Opportunities
- Government initiatives lead to market segment expansion
The government is also making efforts to raise awareness of different parasitic infections. Additionally, government organizations are launching campaigns in developing nations to diagnose and treat diseases. For instance, the government of Japan set up three research and training centers to combat parasitic diseases after the global parasite control initiative was proposed. Governmental organizations' investments are also accelerating market expansion in the area.
- Technological progress enables market expansion
Fecal identification, morphological identification, immunological techniques, molecular techniques, rapid diagnostic tests (RDTS), MALDI-TOF MS, and other procedures are the most frequently used techniques for parasitology identification. Rising parasite testing rates, expanding federal body awareness campaigns globally, growing smartphone usage for parasite identification, and emerging technological trends are all expected to expand the parasitology identification market.
Restraints/Challenges
- Expensive detection restricts the market
Molecule-based identification methods are accurate, sensitive, and susceptible. Additionally, the high cost of the devices, RT PCR, and MALDI-TOF are two major molecular technique drawbacks. The utility in developing countries is constrained, and the development of pricy detection devices is limited. With factors such as the rise in chronic infectious diseases, increased government involvement, and the use of machine learning and artificial intelligence for parasite detection and diagnosis, the market for parasite identification is expanding. Higher diagnostic costs and incorrect data interpretation could hamper the market expansion during the forecasting period.
- Labor- and time-intensive processes may limit growth
The typical parasite identification technique uses a microscope. Using microscopes, parasites can be found in samples of blood smears, feces, lymph node aspirates, tissues, or cerebrospinal fluid; however, sample preparation for observation under microscopes is labor-intensive and time-consuming, which restricts the growth of the field.
This parasitology identification market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the parasitology identification market contact Data Bridge Market Research for an analyst brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2020, Abbott conducted a malaria study in the Mpigi district using its most recent rapid diagnostic malaria kit and the standard test currently available on the market. Abbott's quick diagnostic test showed some ground-breaking results, with a doubled positivity rate compared to the standard test. This has improved the company's brand value in the marketplace.
- In 2020, BD received approval for its automated flow cytometer system, the BD FACSDUET. By increasing accuracy and standardization from instrument to instrument and operator to operator, automation solutions for flow cytometry like the BD FACSDuetTM and BD FACSLyricTM Complete Sample-to-Answer Solution help to increase throughput and provide consistent results that clinicians rely on to guide patient care.
Global Parasitology Identification Market Scope
The parasitology identification market is segmented on the basis of product, method, pathogen type, sample, stool concentration and preparation, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Products
- Consumables and Accessories
- Devices
- Polymerase Chain Reaction (PCR)
- Madd Spectrometers
- Microscopes
- Polystrainers
- Flow Cytometers
- Others
Methods
- Microscopic ideantification
- Fecal Identification
- Immunological Techniques
- Enzyme linked immunosorbent Assay (ELISA)
- Heamaggulutination Assay
- Others
- Morphological Identification
- Molecular Techniques
- Rapid Diagnostic Tests (RDTs)
- Maldi-TOF MS
- Others
Pathogen Type
- Protozoan
- Helminths
- Arthropodes
- Tapeworm
- Ectoparast
Sample
- Feces
- Blood
- Urine
- Cerebrospinal fluid (CSF)
- Serum and Plasma
- Others
Stool Concentration and Preparation
- Concentration Technique
- Un-Concentration Technique
End User
- Diagnostic Centers
- Hospitals
- Clinics
- Ambulatory surgical centers
- Others
Global Parasitology Identification Market Regional Analysis/Insights
The parasitology identification market is analysed and market size insights and trends are provided by country, product, method, pathogen type, sample, stool concentration and preparation, and end user as referenced above.
The countries covered in the parasitology identification market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the market and will continue to flourish its trend of dominance during the forecast period. The major factors attributable to the region’s dominance are the largest consumer market and high gross domestic product are present. The U.S., which dominates the parasitology identification market in North America, is anticipated to grow at a CAGR over the course of the forecast period due to factors including rising healthcare costs, increased parasitology-related research and development, and trending diagnostic tool advancements.
Asia-Pacific will undergo the highest growth rate during the forecast period owing upgradation of medical infrastructure-driven parasitology identification and federal bodies’ initiatives. China is expected to dominate in the market in the Asia-Pacific market. With its rapidly rising product usage and advancements in parasitology identification, China is one of the top nations in the world.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Parasitology Identification Market Share Analysis
The parasitology identification market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to parasitology identification market.
Some of the major players operating in the parasitology identification market are:
- Abbott (U.S.)
- BD (U.S.)
- bioMérieux, Inc.(France)
- Bruker (U.S.)
- Quest Diagnostics (U.S.)
- Akron Biotech (U.S.)
- Thermo Fisher Scientific Inc (U.S.)
- altona Diagnostics GmbH (Germany)
- Biomerica (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Creative Diagnostics (U.S.)
- Luminex Corporation (U.S.)
- Meridian Bioscience, Inc. (U.S.)
- R-Biopharm AG (Germany)
- Shimadzu Corporation (Japan)
- Institut Virion/Serion (Germany)
- VWR International, LLC. (U.S.)
- Hardy Diagnostics (U.S.)
- TECHLAB, Inc. (U.S.)
- Alpha-Tec (U.S.)
- Medical Chemical Corporation (MCC). (U.S.)
SKU-